- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Immunosyn Corp+ Add to Watchlist
IMYN:US0.0006 USD 0.0005 45.45%
As of 20:10:00 ET on 07/24/2014.
Company Profile for Immunosyn Corp (IMYN)
Immunosyn Corporation owns the exclusive worldwide license to market a biopharmaceutical drug used to treat chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers.
Key Executives for Immunosyn Corp (IMYN)
|Douglas A McClain JrChair/CFO/Chief Accounting Ofcr||Stephen D FerronePresident/CEO|